Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or side effect disclosures. These compounded drugs, unlike generics, are not ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Does Compounded Semaglutide Work for Weight Loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...

The runaway popularity of GLP-1 medications like Ozempic and Wegovy for weight loss and diabetes management led to a nationwide shortage that lasted more than a year—and created the perfect conditions ...

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to RegulationsSAN DIEGO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- As the post-holiday period brings ...

Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short, and ...

Many Americans have turned to compounding pharmacies to get popular weight-loss drugs due to lack of availability or expensive retail price tags. But this option will soon close for consumers. The ...

The mounting conversations around compounded GLP-1 medications aren’t just about science or safety. Rather, lawsuits and corporate power plays have had massive influence on how these drugs are being ...

FDA issued a statement about the importance of reporting adverse events resulting from the use of compounded drugs. Janet Woodcock, MD, director of FDA’s Center for Drug Evaluation and Research, ...

A compounding pharmacy can be defined as a pharmaceutical facility that specializes in creating medications customized to personalized prescriptions. These prescriptions are customized based on ...

Sprout Health Serves as Case Study for Provider Model Structure, Program Costs, and FDA-vs-Compounded Disclosure ...